版本:
中国

BRIEF-PharmaMar, Eczacıbaşı sign licensing agreement for Aplidin in Turkey

May 25 Pharma Mar Sa:

* Announced licensing agreement with Eczacibaşi Group to commercialize marine-derived anticancer drug Aplidin (Plitidepsin) in Turkey

* Under terms, co will receive an upfront payment as well as development milestones related to health approval procedure of Aplidin

* Co will retain exclusive production rights and will supply finished product to Eczacibaşi for commercial use Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐